当前位置:首页 - 行情中心 - 盟科药业-U(688373) - 财务分析 - 现金流量表

盟科药业-U

(688373)

  

流通市值:33.84亿  总市值:42.22亿
流通股本:5.25亿   总股本:6.56亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金110,478,494.5571,051,858.1835,067,130.44136,564,457.98
  收到的税费返还--7,116.29-
  收到其他与经营活动有关的现金7,228,482.73,144,631.54486,110.293,583,922.63
  经营活动现金流入小计117,706,977.2574,196,489.7235,560,357.02140,148,380.61
  购买商品、接受劳务支付的现金182,874,873.43121,952,806.8646,912,769.88415,605,712.61
  支付给职工以及为职工支付的现金79,617,413.4854,785,443.0630,134,745.33111,016,552.89
  支付的各项税费10,972,264.6510,458,533.091,028,859.2427,001,335.13
  支付其他与经营活动有关的现金9,870,452.557,704,385.499,532,177.833,705,515.31
  经营活动现金流出小计283,335,004.11194,901,168.587,608,552.25587,329,115.94
  经营活动产生的现金流量净额-165,628,026.86-120,704,678.78-52,048,195.23-447,180,735.33
二、投资活动产生的现金流量:
  收回投资收到的现金1,925,256,071.611,392,059,812.89848,173,313.792,987,343,569.58
  取得投资收益收到的现金5,350,663.783,719,749.168,618,023.0720,173,016.38
  处置固定资产、无形资产和其他长期资产收回的现金净额3,789.51--27,456.31
  投资活动现金流入小计1,930,610,524.91,395,779,562.05856,791,336.863,007,544,042.27
  购建固定资产、无形资产和其他长期资产支付的现金631,741.98259,932.3523,187914,765.44
  投资支付的现金1,753,093,752.881,357,980,818.93812,864,268.512,491,831,053.84
  投资活动现金流出小计1,753,725,494.861,358,240,751.28812,887,455.512,492,745,819.28
  投资活动产生的现金流量净额176,885,030.0437,538,810.7743,903,881.35514,798,222.99
三、筹资活动产生的现金流量:
  吸收投资收到的现金---1,977,035
  取得借款收到的现金91,702,238.6971,702,238.6964,479,490.67105,000,000
  筹资活动现金流入小计91,702,238.6971,702,238.6964,479,490.67106,977,035
  偿还债务支付的现金19,743,974.5512,010,0005,500,00017,020,000
  分配股利、利润或偿付利息支付的现金6,517,474.14,303,012.12,027,8186,542,266.07
  支付其他与筹资活动有关的现金11,389,209.97,716,039.18-15,319,991.19
  筹资活动现金流出小计37,650,658.5524,029,051.287,527,81838,882,257.26
  筹资活动产生的现金流量净额54,051,580.1447,673,187.4156,951,672.6768,094,777.74
四、汇率变动对现金及现金等价物的影响-1,608,325.68-934,222.35-102,090.07143,372.07
五、现金及现金等价物净增加额63,700,257.64-36,426,902.9548,705,268.72135,855,637.47
  加:期初现金及现金等价物余额273,332,290.62273,332,290.62273,332,290.62137,476,653.15
  期末现金及现金等价物余额337,032,548.26236,905,387.67322,037,559.34273,332,290.62
补充资料:
  净利润--138,674,492.55--440,721,217.09
  固定资产和投资性房地产折旧-1,154,661.21-2,262,567.82
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-1,154,661.21-2,262,567.82
  无形资产摊销-439,071.2-492,740.52
  长期待摊费用摊销-1,528,453.14-2,999,610.23
  处置固定资产、无形资产和其他长期资产的损失----27,456.31
  固定资产报废损失--4,427.63--
  公允价值变动损失--4,261,022.11--17,081,843.88
  财务费用-4,813,649.95-12,015,538.85
  存货的减少-2,416,801.55--15,416,618.4
  经营性应收项目的减少--2,882,985.89--24,409,153.56
  经营性应付项目的增加--6,768,929.53--18,370,359.83
  不涉及现金收支的投资和筹资活动金额其他项目---3,176,680.18
  现金的期末余额-236,905,387.67-273,332,290.62
  减:现金的期初余额-273,332,290.62-137,476,653.15
  现金及现金等价物的净增加额--36,426,902.95-135,855,637.47
公告日期2025-10-282025-08-202025-04-242025-03-18
审计意见(境内)标准无保留意见
TOP↑